As an immune-mediated demyelinating disease, could multiple sclerosis
(MS) be treated by myeloablative therapy followed by bone marrow trans
plantation? Richard Burt and colleagues discuss preliminary data on th
is approach in the MS model of experimental allergic encephalomyelitis
and in MS patients.